NCT06409221View on ClinicalTrials.gov

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

December 31, 2025

Conditions
Cancer, BreastTriple Negative Breast CancerEarly-stage Breast Cancer
Interventions
OTHER

Non-interventional study, Observational only

Observational study only, there are no planned interventions.

Trial Locations (1)

Unknown

Royal Marsden Hospital, London

Sponsors

Lead Sponsor

Concr
All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

Durham University

OTHER

lead

Concr

INDUSTRY

NCT06409221 - VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study | Biotech Hunter | Biotech Hunter